Neuropeptide Y (13-36) (porcine) trifluoroacetate salt

Modify Date: 2024-01-02 15:27:06

Neuropeptide Y (13-36) (porcine) trifluoroacetate salt structure	Common Name	Neuropeptide Y (13-36) (porcine) trifluoroacetate salt
	CAS Number	113662-54-7	Molecular Weight	2982.36000
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₃₅H₂₀₉N₄₁O₃₆	Melting Point	N/A
	MSDS	USA	Flash Point	N/A

Use of Neuropeptide Y (13-36) (porcine) trifluoroacetate salt

Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist[1].

Name	Neuropeptide Y Fragment 13-36 porcine
Synonym	More Synonyms

Description	Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> Neuropeptide Y Receptor
References	[1]. Aguirre JA, et al. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8.

Molecular Formula	C₁₃₅H₂₀₉N₄₁O₃₆
Molecular Weight	2982.36000
Exact Mass	2980.58000
PSA	1282.86000
LogP	5.51400

MSDS(Chinese)

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR	NONH for all modes of transport

Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.

J. Neurochem. 73 , 641-646, (1999)

Neuropeptide Y (NPY) is an important regulator of energy balance in mammals through its orexigenic, antithermogenic, and insulin secretagogue actions. We investigated the regulation of endogenous NPY ...

Neuropeptide Y produces anxiety via Y2-type receptors.

Peptides 19 , 359-363, (1998)

In the present study, the effects of intracerebroventricular (ICV) NPY, [Leu31, Pro34]NPY and NPY13-36 have been evaluated with respect to anxiety in mice in the elevated plus maze. NPY had opposing e...

Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes.

Eur. J. Pharmacol. 336 , 257, (1997)

The aim of this study was to confirm the existence of and identify the receptor subtypes for neuropeptide Y that are present post-junctionally in myocardium. The effects of the selective agonists, [Le...

npy 13-36

PAEDLARYYSALRHYINLITRQRY-NH2